Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to

Updated on: September 27,2024

Palliative low-dose radiotherapy improves pain in hepatic cancer

by Elana GotkineFor adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to

Updated on:September 27,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on: February 18,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on:February 18,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on: April 30,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on:April 30,2024

New study identifies ganoderic acid DM as potential treatment for breast cancer

byChinese Academy of SciencesProtein-protein interaction network of the 53 potential targets for treating breast cancer. Credit: Mohammed Sharif SwallahBreast cancer is one of the most common ca

Updated on: October 22,2024

New study identifies ganoderic acid DM as potential treatment for breast cancer

byChinese Academy of SciencesProtein-protein interaction network of the 53 potential targets for treating breast cancer. Credit: Mohammed Sharif SwallahBreast cancer is one of the most common ca

Updated on:October 22,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on: March 05,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on:March 05,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on: January 03,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on:January 03,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on: February 23,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on:February 23,2024

Incarceration associated with higher cancer mortality, study shows

byYale UniversityCredit: Pixabay/CC0 Public DomainNew research from Yale Cancer Center reveals a higher risk of cancer mortality in incarcerated adults, as well as among those diagnosed with can

Updated on: January 22,2024

Incarceration associated with higher cancer mortality, study shows

byYale UniversityCredit: Pixabay/CC0 Public DomainNew research from Yale Cancer Center reveals a higher risk of cancer mortality in incarcerated adults, as well as among those diagnosed with can

Updated on:January 22,2024

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on: March 30,2024

Immune evasion tactics of liver cancer cells revealed

byeLifeActivated ß-catenin represses immune infiltration in liver cancer spheroids through exosomes. (a) Peripheral Blood Mononuclear Cells (PBMC) infiltration analysis protocol. Created with Bi

Updated on:March 30,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on: May 06,2024

Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows

by Julia Evangelou Strait,Washington University School of MedicineNew research from Washington University School of Medicine in St. Louis shows that blocking a major inflammatory pathway in panc

Updated on:May 06,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024

Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy

by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and

Updated on: January 13,2024

Newly developed PSG score improves patient selection for PSMA radiopharmaceutical therapy

by Society of Nuclear Medicine and Molecular ImagingRepresentative PET images of 6 patients classified as having high, intermediate, and low visual PSG scores. Credit: Society of Nuclear Medicine and

Updated on:January 13,2024